Synthesis and antitumor activities of fluoroquinolone C-3 isosteres(IV):<i>s</i>-triazole-oxadiazole methylsulfide Mannich-base derivatives

SUN Yusheng; XU Qiuju; HOU Lili; YUE Xibo; WU Zhaofeng; HUANG Wenlong; XIE Songqiang; HU Guoqiang

doi:10.11665/j.issn.1000-5048.20140106

Journal of China Pharmaceutical University > 2014 > 45(1): 39-42. > DOI: 10.11665/j.issn.1000-5048.20140106

SUN Yusheng, XU Qiuju, HOU Lili, YUE Xibo, WU Zhaofeng, HUANG Wenlong, XIE Songqiang, HU Guoqiang. Synthesis and antitumor activities of fluoroquinolone C-3 isosteres(IV):s-triazole-oxadiazole methylsulfide Mannich-base derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 39-42. DOI: 10.11665/j.issn.1000-5048.20140106

Citation:

PDF (1068 KB)

Synthesis and antitumor activities of fluoroquinolone C-3 isosteres(IV):s-triazole-oxadiazole methylsulfide Mannich-base derivatives

More Information

Graphical Abstract

Abstract

Abstract

To search for an efficient modification strategy for a bioisostere of the C-3 carboxylic acid group of antitumor fluoroquinolones, an aminomethylation reaction based on the structural characteristics of the C-3 s-triazole-oxadiazole sulfides( 6a - 6j )was carried out on a five-member azole ring of s-triazole to give 1-ethyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-3-［1-dimethy-l amino-methyl-5-(5-substituted-phenyl-［1, 3, 4］oxadia-zol-2-yl methylsulfanyl)-1H-［1, 2, 4］-triazol-3-yl］-quinolin-4(1H)-ones( 7a - 7j )as novel C-3 s-triazole-oxadiazole sulfide Mannich-base derivatives starting from pefloxacin( 1 ). The structures of the title compounds were characterized by elemental analysis and spectral data and their in vitro antitumor activity against SMMC-7721, L1210 and HL60 cell lines was evaluated by a MTT assay. The results showed that the of sulfides( 6a - 6j )and their corresponding Mannich-base compounds( 7a - 7j )had more potent inhibitory activity than the compound 1 , and the Mannich-base compound 7 also exhibited more potent cytotoxicity than the corresponding compound 6 , especially both had better activity against SMMC-7721 cell line than the other cancer cell lines.
- fluoroquinolone,
- s-triazole,
- oxadiazole,
- synthesis,
- sulfide,
- bioisostere,
- Mannich-base,
- antitumor activity

FullText(HTML)

References (10)

References

[1]	Guo ZR.Strategy of molecular drug design:hits leads and drug candidates[J].Acta Pharm Sin(药学学报),2008,43(9):898-904.
[2]	Hinsberger S,Hüsecken K,Groh M,et al.Discovery of novel bacterial RNA polymerase inhibitors:pharmacophore based virtual screening and hit optimization[J].J Med Chem,2013,56(21):8 332-8 338.
[3]	Khadka DB,Cho WJ.Topoisomerase inhibitors as anticancer agents:a patent update[J].Expert Opin Ther Pat,2013,23(8):1 033-1 056.
[4]	Fisher LM,Pan XS.Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities[J].Methods Mol Med,2008,142:11-23.
[5]	Heeb S,Fletcher MP,Chhabra SR,et al.Quinolones:from antibiotics to autoinducers[J].FEMS Microbiol Rev,2011,35(2):247-274.
[6]	Sun JP,Shi ZY,Liu SM,et al.Trimethoxy-benzaldehyde levofloxacin hydrazone inducing the growth arrest and apoptosis of human hepatocarcinoma cells[J].Cancer Cell Int,2013,13(1):67-73.
[7]	Hu GQ,Hou LL,Wang GQ,et al.Design,synthesis and antitumor activity of fluoroquinolone C-3 heterocycles:bis-oxadiazole methylsulfide derivatives derived from ciprofloxacin[J].Acta Pharm Sin(药学学报),2012,47(8):1 017-1 022.
[8]	You QD,Li ZY,Huang CH,et al.Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification[J].J Med Chem,2009,52(18):5 649-5 661.
[9]	Xu QJ,Hou LL,Wu ZF,et al.Synthesis and antitumor activity of fluoroquinolone C3 isostere Ⅲ:s-triazole oxadiazole methylsulfide derivatives from pefloxacin[J].J China Pharm Univ(中国药科大学学报),2013,44(6):511-514.
[10]	Shivarama Holla B,Veerendra B,Shivananda MK,et al.Synthesis characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles[J].Eur J Med Chem,2003,38(7/8):759-767.

[1]	TANG Xiaohang, SONG Huilin, YAO Liying, QIN Guowen, WANG Xingchen, LIU Wenyuan, JI Shunli. Determination of non-steroidal anti-inflammatory drugs in the environmental water samples by a polyvinylimide-modified magnetic nanoparticles-based solid phase extraction coupled with high-performance liquid chromatography[J]. Journal of China Pharmaceutical University, 2024, 55(4): 485-492. DOI: 10.11665/j.issn.1000-5048.2023081802
[2]	BAO Xiaoqiang. Effects of co-culture supernatant of Lactobacillus casei and Bacillus subtiliis natto on intestinal microecology, mucosal barrier function and immune function in mice with antibiotic-associated diarrhea[J]. Journal of China Pharmaceutical University, 2020, 51(1): 92-98. DOI: 10.11665/j.issn.1000-5048.20200114
[3]	ZENG Ye, ZHOU Zixuan, SUN Xun. Preparation of sheddable PEG modified miRNA-complexing nanoparticles and its preliminary in vitro and in vivo study[J]. Journal of China Pharmaceutical University, 2016, 47(6): 702-707. DOI: 10.11665/j.issn.1000-5048.20160612
[4]	CHI Huibo, XU Tingting, CHEN Hongyan, CAO Feng. Ophthalmic solution of pirenoxine sodium-layered double hydroxide nanosheets and intercalated nanoparticles[J]. Journal of China Pharmaceutical University, 2016, 47(4): 448-456. DOI: 10.11665/j.issn.1000-5048.20160410
[5]	LI Yanan, WANG Jue, LI Ji, SHEN Yan, TU Jiasheng. Co-delivery of siRNA and docetaxel by hyaluronic acid modified redox-sensitive disulfide-crosslinked nanoparticles[J]. Journal of China Pharmaceutical University, 2016, 47(4): 429-436. DOI: 10.11665/j.issn.1000-5048.20160407
[6]	ZHANG Yin, MENG Chen, CHANG Jun, SHA Sha, CHEN Hao, LU Suo. Preparation and characterization of a self-assembled tea polyphenol-gelatin-chitosan nanoparticles[J]. Journal of China Pharmaceutical University, 2014, 45(2): 178-184. DOI: 10.11665/j.issn.1000-5048.20140209
[7]	LIU Congyan, WANG Wei, ZHOU Jianping, DING Yang, ZHOU Xin, WANG Zhaoxian. Preparation and evaluation of gambogic acid-loaded reconstituted high density lipoprotein nanoparticles[J]. Journal of China Pharmaceutical University, 2013, 44(4): 311-315. DOI: 10.11665/j.issn.1000-5048.20130405
[8]	TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572.
[9]	XU Xiang-yang, LI Ling, WANG Qing-song, LIU Chun-hui. Preparation and in vitro evaluation of chitosan nanoparticles encapsulating recombinant human endostatin[J]. Journal of China Pharmaceutical University, 2011, 42(1): 44-47.
[10]	Advances in nanoparticle system for deliverying drugs across the biological barriers[J]. Journal of China Pharmaceutical University, 2002, (3): 3-6.

Cited By

Cited by

Periodical cited type(2)

1.	李焱琳，王琪. 干扰素介导肿瘤免疫分子机制的相关研究进展. 临床合理用药. 2025(02): 177-180 .
2.	梅家豪，洪泽，王琛. 靶向cGAS-STING信号通路药物的研究进展. 中国药科大学学报. 2020(03): 249-259 . 本站查看

Other cited types(0)

Get Citation

PDF

XML

Article views (1291) PDF downloads (1503) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Synthesis and antitumor activities of fluoroquinolone C-3 isosteres(IV):s-triazole-oxadiazole methylsulfide Mannich-base derivatives

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Synthesis and antitumor activities of fluoroquinolone C-3 isosteres(IV):s-triazole-oxadiazole methylsulfide Mannich-base derivatives

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Export File

Citation

Format

Content